Roche receives FDA authorisation for testing of asymptomatic people with the cobas SARS-CoV-2 Test to help control the spread of COVID-19
The high-throughput, highly sensitive cobas SARS-CoV-2 Test under FDA Emergency Use Authorisation can now be used to test individual or pooled samples from people without symptoms or other reasons to suspect COVID-19
Accurate, reliable and early detection of SARS-CoV-2 in potentially exposed individuals can help limit the spread of disease
PLEASANTON, Calif., May 18, 2021 /PRNewswire/ Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its
cobas SARS-CoV-2 Test for use on the widely available, high-throughput
cobas 6800/8800 Systems has received Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA) for testing individuals without symptoms or reasons to suspect COVID-19. This authorisation supports the guidance update from the U.S. Centers for Disease Control and Prevention (CDC) to expand SARS-CoV
Kentucky-based Testing Lab Solaris Diagnostics Donates 1,000 Oxygen Concentrators to India Orgs massachusettsnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from massachusettsnewswire.com Daily Mail and Mail on Sunday newspapers.
NICHOLASVILLE, Ky., May 14, 2021 (SEND2PRESS NEWSWIRE) â Solaris Diagnostics, a CLIA certified clinical laboratory in Nicholasville Kentucky, has shipped 1,000 donated oxygen concentrators, worth more than $700 thousand dollars, to India.
These oxygen concentrators are now providing life-saving relief to the millions of patients suffering from the devastating second wave of COVID-19 cases in India. The donated supplies began arriving this week and currently aid three Indian organizations: Office of District Collector and Magistrate, Hanumangarh, Rajasthan KhalsaAid India and Sewa International.
With more than 348,000 new cases reported and death numbers exceeding 4,200 daily, the country is experiencing a shortage in beds and oxygen supplies, resulting in dying patients being denied access into the hospitals.
Seattle, WA (PRWEB) May 12, 2021 InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today that
Purpose
Form 3228 is used to apply for an initial, change of ownership or relocation license for a general or special hospital. Contact Health Facility Licensing at 512-834-6648 with any questions.
When to Prepare
The application, fees and other documents shall be submitted as required by 25 Texas Administrative Code (TAC), Chapter 133, Hospital Licensing Rules, §133.22 Application and Issuance of Initial License. Information regarding licensure for health care facilities, including contact information for the Health Facility Compliance Office for each location, is located on the Texas Health and Human Services website at https://hhs.texas.gov/doing-business-hhs/provider-portals/health-care-facilities-regulation/hospitals-general-hospitals.
The following documents, fees and actions shall be completed and approved before a license will be issued: